This move is expected to benefit 22 lakh cancer patients in the country and would result in annual savings of around Rs 800 crore to the patients, the release said.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2UrR33A
via IFTTT
Prices of 390 non-scheduled cancer medicines slashed by up to 87 per cent
This move is expected to benefit 22 lakh cancer patients in the country and would result in annual savings of around Rs 800 crore to the patients, the release said.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2UrR33A
via IFTTT
0 comments:
Post a Comment